Integra LifeSciences Schedules Conference Call for Friday, February 27 to Discuss Fourth Quarter and Full Year 2003 Financial Results and Update Forward- Looking Financial Guidance
PLAINSBORO, N.J.--(BUSINESS WIRE)--Feb. 13, 2004--Integra LifeSciences Holdings Corporation (Nasdaq:IART) has scheduled a conference call for 9:00 AM EST on Friday, February 27 to discuss financial results for the fourth quarter and year ended December 31, 2003 and to update forward-looking financial guidance. Financial results for the fourth quarter and full year 2003 will be announced via a news release issued before the market opens on February 27.
The conference call will be hosted by Stuart Essig, President and Chief Executive Officer of Integra, and will be open to all listeners. Additional forward- looking information may be discussed in a question and answer session following the call.
Access to the live call is available by dialing 973-935- 8511 or through a webcast via a link provided on Integra's website at www.Integra-LS.com. Access to a replay is available through March 12 by dialing 973-341- 3080 (PIN 4418658) or through the webcast.
Integra LifeSciences Holdings Corporation is a diversified medical technology company that develops, manufactures, and markets medical devices for use in a variety of applications. The primary applications for Integra's products are neuro-trauma and neurosurgery, plastic and reconstructive surgery and general surgery. Integra is a leader in applying the principles of biotechnology to medical devices that improve patients' quality of life. Our corporate headquarters are in Plainsboro, New Jersey, and we have manufacturing and research facilities located throughout the world.
CONTACT: Integra LifeSciences Holdings Corporation
Maria Platsis (Investor Relations), 609-936-2333
mplatsis@integra-ls.com
or
John Bostjancic (Finance), 609-936-2239
jbostjancic@integra-ls.com
SOURCE: Integra LifeSciences Holdings Corporation